⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
XERS News
Xeris Biopharma Holdings, Inc. Common Stock
Xeris Biopharma to Report Second Quarter 2026 Financial Results on August 6, 2026
businesswire.com
XERS
Form 8-K
sec.gov
XERS
CORRECTING and REPLACING Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
businesswire.com
XERS
CORRECTING and REPLACING Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
businesswire.com
XERS
Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
businesswire.com
XERS
Form 8-K
sec.gov
XERS
Xeris Announces Updates to Its Board of Directors
businesswire.com
XERS
Xeris Biopharma Announces Notice of Allowance From U.S. Patent and Trademark Office for New Patent Covering KEVEYIS ®
businesswire.com
XERS
Form 8-K
sec.gov
XERS
Xeris Biopharma Announces Private Exchange of Convertible Notes
businesswire.com
XERS